☆ 4.6 Article

Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience

Marco Schiavone et al.

Summary: The study investigated the impact of OAC and heparin treatment on COVID-19 patients, showing that OAC was ineffective in reducing mortality rate, while heparin had a protective effect in severe lung disease, potentially indicating a crucial role of microthrombosis in the disease. Larger studies are needed to confirm these findings.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Article Critical Care Medicine

Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning

Saeed Mirsadraee et al.

Summary: This study analyzed 72 critically ill patients with severe coronavirus disease 2019 and found a high prevalence of thrombotic complications, especially pulmonary thromboses, in 58% of the patients. The detection of thrombus was usually incidental, not predicted by coagulation or inflammatory biomarkers, and associated with increased risk of death.

CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study

Gentian Denas et al.

Summary: Among elderly patients with COVID-19, those on chronic oral anticoagulant treatment for atrial fibrillation seem to have a lower risk of all-cause mortality compared to their non-anticoagulated counterparts in a propensity score matched cohort. The finding warrants further confirmation in additional studies.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Direct oral anticoagulant use and risk of severe COVID-19

B. Flam et al.

Summary: The study found that ongoing DOAC use was not associated with reducing the risk of severe COVID-19, suggesting that early outpatient DOAC initiation would not modify prognosis.

JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Review Respiratory System

COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms

Joan Loo et al.

Summary: Thrombotic events in COVID-19, especially venous thromboemboli, are associated with disease severity and poor clinical outcomes. Distinctive microvascular abnormalities include endothelial inflammation, disruption of intercellular junctions, and microthrombi formation. COVID-19 can lead to immunothrombosis, and a better understanding of the pathobiological mechanisms is crucial for developing new treatments.

THORAX (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Prophylactic anticoagulation for patients in hospital with covid-19

Beverley J. Hunt et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study

Christopher T. Rentsch et al.

Summary: The study found that early initiation of prophylactic anticoagulation was associated with decreased risk of 30 day mortality among patients hospitalized with covid-19 in the United States, without increasing the risk of serious bleeding events.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study

Richard Chocron et al.

Summary: The study found that COVID-19 patients receiving anticoagulation therapy before hospitalization had a better prognosis, while those starting anticoagulation therapy during hospitalization were not associated with any outcomes. Early introduction of anticoagulation therapy can help prevent COVID-19-associated coagulopathy and endotheliopathy, leading to a better prognosis for patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Add to Collection

Article Pharmacology & Pharmacy

Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: A propensity score-matched cohort study

Janneke P. Spiegelenberg et al.

Summary: This study found that prior use of therapeutic anticoagulation is not associated with improved clinical outcomes in hospitalized COVID-19 patients.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Add to Collection

Article Hematology

Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study

Douglas Tremblay et al.

BLOOD (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China Prevalence, Risk Factors, and Outcome

Li Zhang et al.

CIRCULATION (2020)

Add to Collection

Review Physiology

Heparin as a therapy for COVID-19: current evidence and future possibilities

Joseph A. Hippensteel et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)

Add to Collection

Article Hematology

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

Hanny Al-Samkari et al.

BLOOD (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Elevatedd-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019 A Systematic Review and Meta-Analysis

Siddharth Shah et al.

CARDIOLOGY IN REVIEW (2020)

Add to Collection

Letter Medicine, General & Internal

Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System

Seda Bilaloglu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Add to Collection

Letter Hematology

Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom

Michael J. R. Desborough et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Review Medicine, General & Internal

Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients

Baranca Buijsers et al.

EBIOMEDICINE (2020)

Add to Collection

Article Hematology

Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up

Richard Salisbury et al.

BLOOD ADVANCES (2020)

Add to Collection

Review Medicine, General & Internal

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

Mahmoud B. Malas et al.

ECLINICALMEDICINE (2020)

Add to Collection

Review Pharmacology & Pharmacy

Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review

Sarah Mousavi et al.

ADVANCES IN PHARMACOLOGICAL SCIENCES (2015)

Add to Collection

Article Hematology

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

S Schulman et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.